avacta group plc (AVCT:London)
avacta group plc (AVCT) Snapshot
|
Open
0.93 GBp
|
Previous Close
0.93 GBp
|
|
|
Day High
0.93 GBp
|
Day Low
0.93 GBp
|
|
|
52 Week High
01/21/13 - 1.41 GBp
|
52 Week Low
08/30/12 - 0.73 GBp
|
|
|
Market Cap
29.2M
|
Average Volume 10 Days
3.5M
|
|
|
EPS TTM
-0.0005 GBp
|
Shares Outstanding
3.2B
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
avacta group plc (AVCT) Related Businessweek News
No Related Businessweek News Foundavacta group plc (AVCT) Details
Avacta Group plc, a healthcare technology and consumables company, engages in the research, development, and commercialization of analytical and diagnostic technologies, consumables, reagents, and services for drug development and veterinary healthcare markets. The company operates in two divisions, Avacta Analytical and Avacta Animal Health. The Avacta Analytical division provides analytical instrumentation, consumables, and services to the biopharmaceutical sector. It offers Optim, an analytical instrument and its consumable cartridge for use in biological drug development activities; and contract analytical research services focused on supporting characterization, formulation, comparability, and stability studies of biopharmaceutical and diagnostic proteins. This segment markets its product directly in the United Kingdom, as well as through a network of distributors in the United States, southeast Asia, Europe, China, Taiwan, and Japan. The Avacta Animal Health division provides diagnostic products, reagents, and services for the veterinary diagnostics market. It offers AX-1, a point of care immunoassay system that provides veterinarians with rapid serological blood test results in the clinic; and laboratory testing services for veterinary practices worldwide. Avacta Group plc is based in Wetherby, the United Kingdom.
Last Reported Date: 01/30/13
avacta group plc (AVCT) Top Compensated Officers
avacta group plc (AVCT) Key Developments
Avacta Group Plc announced unaudited consolidated earnings results for the six months period ended January 31, 2013. For the period, the company reported revenue of £1,150,000 against £1,717,000 a year ago, due entirely to the reduced volume of sales of the Optim 1000 product. Operating loss before amortization of customer related intangibles and development costs and share based payment charges was £964,000 against £387,000 a year ago. Total operating loss was £974,000 against £515,000 a year ago. Loss before taxation was £957,000 against £506,000 a year ago. Loss for the period was £807,000 against £349,000 a year ago. Loss per basic and diluted ordinary share was 0.03 pence against 0.02 pence a year ago. Net cash flow from operating activities was £863,000 against £262,000 a year ago. Purchase of plant and equipment was £385,000 against £96,000 a year ago. Development expenditure capitalized was £884,000 against £474,000 a year ago. The company announced that the board anticipates an improvement in the operating cash flow in the second half reflecting a more positive outlook in the sales of Optim2 but is mindful of the need to keep a tight control of all expenditures.
Avacta Group Plc, H1 2013 Earnings Call, Apr 30, 2013
Avacta Group Plc announced that they will report first half, 2013 results on Apr 30, 2013
| Recently Viewed | |||
| AVCT:LN | 0.93 GBp | 0.00 | |
| Company | Last | Change | |
| No competitor information is available for AVCT. | |||
| View Industry Companies | |||
Industry Analysis
AVCT
Industry Average
| Valuation | AVCT | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 9.3x |
|
| Price/Book | 1.5x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 10.9x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact AVACTA GROUP PLC, please visit www.avacta.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.







